Crescent Capital

Bioscience Managers is an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare. Bioscience Managers invests in private and public healthcare companies with clear technological and market advantages in any territory, where we are confident that our engagement with management will deliver commercial success and returns for investors. We are both geographically and therapeutically agnostic. We invest in public and private healthcare companies in any territory which work in therapeutics, medical devices, diagnostics or digital health, which are in or near clinical development or commercialisation. Our strategy is to take a a meaningful stake in our investee companies, including board representation, advisory and or hands-on-roles to augment existing skills and to build a proactive and supportive relationships. We are part of the PhillipCapital Group, which has £30bn under management across 16 offices around the world.

Portland House Group manages the capital of the Australian-based Hains family. Portland House invests in equities (local and global), fixed income, currencies, and asset managers including hedge funds.

Tanarra is a diversified investment manager investing for superannuation funds, financial institutions and family offices across private and public equity, debt, venture capital and special situations; its venture activities include Tanarra Ventures and Tin Alley Ventures.

Allectus Capital is an investor in disruptive technology companies in the Asia Pacific and United Kingdom. We invest in both listed and unlisted companies and partner with and support our investment companies through regular management contact and active communication across our portfolio. Allectus Capital likes to be the first investor in our high conviction portfolio investments. However, we invest across early to late stage deals ranging from very small to very large. Our first cheque is usually $300k - $3m AUD and we look to invest in subsequent rounds where they have gained traction. Allectus Capital is owned by ICM, an international fund manager based in Bermuda, and UIL Limited.

Light Warrior is Radek Sali's private investment firm. Radek Sali was previously the CEO of Swisse vitamins and led the business over a 10 year growth period to a $1.7bn sale in 2015. Light Warrior invests in a variety of businesses, from early stage startups to more established businesses. Light Warrior is a socially minded, positive and principle-driven investment firm. Investments to date include an investment in Jimmy Grants food outlets, Hydralyte, Made by Cow, and Stratosphere Agency.

BMH Capital provides corporate and venture advisory and capital-markets services; BMH Ventures invests from seed through late-stage private rounds.

IFM Investors is one of Australia's leading investors, with a strong track record of investment across four key asset classes: debt investments, listed equities, infrastructure and private equity. With respect to private equity, IFM looks for minority or majority investments in Australian and New Zealand mid-market ($50m to $300m valuation) growth companies. IFM is sector agnostic, however particularly likes healthcare, consumer brands, technology and business services. IFM Investors is owned by 27 Australian superannuation funds.

Regal Partners Limited is an ASX-listed, specialist alternative investment manager providing investors with access to a diverse range of strategies covering hedge funds, private markets and real assets.

Our investment approach is designed to focus on opportunities the market may have overlooked, exploiting inefficiencies by identifying stocks that are temporarily misunderstood and fundamentally mispriced. Our funds target a range of strategies, from large and small capitalisation Australian equity, global long short to Australian market neutral and private equity. Our clients include Government, industry and corporate superannuation funds, international funds as well as individual investors via leading investment administration platforms and a growing number of financial advisors.

Pacific Equity Partners (PEP) is the largest private equity firm in Australia and New Zealand. PEP invests through buyouts and growth capital into a wide range of industries including industrial services, energy, consumer products, entertainment and financial services. PEP prefers to invest in companies with major operations in Australia or New Zealand and with Enterprise Values between A$200m and A$1bn. It typically invests for between three and six years. PEP was founded in 1998 by senior Australian partners of the leading strategy consulting firm Bain & Co.

BGH Capital is an Australian private equity firm founded in 2017. It focuses on buyout and growth investments across a range of industries in Australia and New Zealand.

CP2 is a specialist infrastructure investment manager and has been a global leader in infrastructure investing and asset management for 17 years. We invest in core infrastructure assets that provide secure, stable, inflation-protected cash flows over the long term, and often partners with like-minded investors such as sovereign wealth funds. CP2 focuses on specialist infrastructure; transport including roads, airport, railway, and ports; utilities including power, water, and communication; and social including health, schools, and law and order. The firm does not invest in generation assets, fringe infrastructure including car parks and satellites, externally managed vehicles, constructor or investment bank sponsored greenfield projects, and social infrastructure. The firm invests in both listed and unlisted opportunities.